Jay S. Stout - 21 Jan 2026 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Technology Officer
Signature: /s/ Tiago Girao, attorney-in-fact for Jay Stout
Issuer symbol: IMVT
Transactions as of: 21 Jan 2026
Net transactions value: -$51,461
Form type: 4
Filing time: 23 Jan 2026, 16:21:29 UTC
Previous filing: 09 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stout Jay S	Chief Technology Officer	C/O IMMUNOVANT, INC., 320 W 37TH STREET, 6TH FLOOR, NEW YORK	/s/ Tiago Girao, attorney-in-fact for Jay Stout	23 Jan 2026	0001702969

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	$51,461	-1,977	-0.99%	$26.03	197,634	21 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on January 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Content

On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on January 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.